Ipamorelin is a synthetic pentapeptide growth hormone-releasing peptide (GHRP) and selective agonist of the ghrelin receptor (GHS-R1a), originally developed by Novo Nordisk in Denmark and first characterised in a landmark 1998 paper in the European Journal of Endocrinology by Raun and colleagues
Ginger tea or chews, bland foods like crackers or broth-based soups, and cold or room-temperature meals often go down easier than hot ones
This injectable medication works by helping to regulate appetite and improve metabolism, making it easier to achieve sustainable weight loss
Last reviewed: May 25, 2026 Last updated: May 25, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
W przypadku m.in
Currently on FDA Category 2 with a PCAC review scheduled for July 2026